Lish Adam MD - Brooklyn, New York 11234

Lish Adam MD is categorized under Doctors in Brooklyn, NY .

Business Name: Lish Adam MD
Contact Person: Adam Lish
Address: 1987 Utica Avenue, Brooklyn, New York 11234
Phone Number: (718) 968-8700
Website Address: flatlands-eyecarecenter.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Morgan Daniel J MD - Brooklyn, NY 11234
Mitchell R Epstein Pc - Brooklyn, NY 11234
Dr. Shawn Yunayev, MD - Brooklyn, NY 11234
Dr Gadi Avshalomov Md - Brooklyn, NY 11234
Addes Alvin MD - Brooklyn, NY 11234
Batterman Amy MD - Brooklyn, NY 11234
Pintea Marcel J MD - Brooklyn, NY 11234
Plaza Medical - Brooklyn, NY 11234
Cataract Institute Eye Center - Brooklyn, NY 11234
Gasstro Biliay Assoc - Brooklyn, NY 11234
Fardman Emil MD - Brooklyn, NY 11234
Vijay Venkatarama MD - Brooklyn, NY 11234
Chernov Valeriy M MD - Brooklyn, NY 11234
Noel Ruthuen A MD - Brooklyn, NY 11234
Ibarra John MD - Brooklyn, NY 11234
Weiner Robert MD - Brooklyn, NY 11234
Joseph L Buono MD - Brooklyn, NY 11234
Mdj Medical P C - Brooklyn, NY 11234
Jaspreet S Sekhon MD - Brooklyn, NY 11234
Franklin Tuere A MD - Brooklyn, NY 11234

The company Lish Adam MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Lish Adam MD, and the business now earns $500.000 to $999.999 per annum.

Lish Adam MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Lish Adam MD, please call Adam Lish with the phone number (718) 968-8700 or visit its single location at 1987 Utica Avenue in Brooklyn, New York 11234.

The location of the single location can also be found using the coordinates 40.62329,-73.92728. Read more details about this business on the webpage flatlands-eyecarecenter.com or follow the company’s social media accounts, on Twitter and on Facebook.